TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07595458: Phase 1 Study on the Safety, Tolerability, and Pharmacokinetics of JST-018 in Healthy Adults

Sponsor: Just-Evotec Biologics · Phase: PHASE1 · Area: INFECTIOUS_VACCINE · Target Enrollment: 48 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$6,397,440

Rescue Site Savings

+$4,218,312

Unlock Full NCT07595458 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07595458 Rescue Dossier →